The level of circulating IGFBPs in the plasma of patients with HCC was different than that from the plasma of healthy donors; however, studies agree that reduction of IGFBP3 and IGFBP7 promotes HCC [95,96,97,98,99]. This evidence concerns the gene IGFBP3 and hepatocellular carcinoma.